Pharma channel feed

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

3 weeks ago
Manufacturing

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

3 weeks ago
R&D

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

3 weeks ago
Coronavirus

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

3 weeks ago
Manufacturing

A new dawn for psy­che­delics? Com­pass could be the first to find out

3 weeks ago
In Focus

Ax­some and Het­ero set­tle patent fight over sleep dis­or­der drug

3 weeks ago
Law

FDA re­jects Savara’s rare lung dis­ease drug over lim­it­ed man­u­fac­tur­ing da­ta

3 weeks ago
FDA+
Manufacturing

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

3 weeks ago
Deals

Liq­uidia wins ap­proval for in­haled hy­per­ten­sion drug in two set­tings, fur­ther­ing ri­val­ry with Unit­ed Ther­a­peu­tics

3 weeks ago
FDA+

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

3 weeks ago
Startups
Deals

Black­stone's GRIN inks epilep­sy li­cens­ing deal with An­geli­ni, clos­es $140M Se­ries D

3 weeks ago
Deals

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

4 weeks ago

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

4 weeks ago
Manufacturing
Law

CHMP clears path for GSK’s Blenrep re­launch, rec­om­mends four oth­er drugs 

4 weeks ago
FDA+

Gilead notch­es an­oth­er Phase 3 win for Trodelvy in triple-neg­a­tive breast can­cer

4 weeks ago
R&D

GSK’s Nu­cala wins COPD ap­proval, stok­ing ri­val­ry with Dupix­ent 

4 weeks ago
FDA+

Roche con­firms over­all sur­vival ben­e­fit for PI3K in­hibitor in breast can­cer

4 weeks ago
R&D

Jazz out­lines full sur­vival da­ta for lung can­cer drug Zepzel­ca

4 weeks ago
R&D

House pass­es Trump tax bill with PBM and or­phan drug re­forms in­clud­ed

4 weeks ago
Law

Cigna, No­vo of­fer low­er GLP-1 prices to lure pa­tients to brand-name drugs

4 weeks ago
Health Tech

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

4 weeks ago
FDA+

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

4 weeks ago
Manufacturing

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

4 weeks ago
Deals

FDA ad­comm votes unan­i­mous­ly against Pfiz­er's prostate can­cer drug com­bo

4 weeks ago
FDA+
First page Previous page 123456 Next page Last page
A service from the Financial Times